+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

3-Kinase Delta Syndrome Market - Global Forecast 2025-2032 - Product Thumbnail Image

3-Kinase Delta Syndrome Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 183 Pages
  • Global
From
Enzyme Inhibitor Market - Global Forecast 2025-2032 - Product Thumbnail Image

Enzyme Inhibitor Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 189 Pages
  • Global
From
From
From
Sickle Cell Disease Treatment Market Report 2025 - Product Thumbnail Image

Sickle Cell Disease Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Industry Snapshots: US Biotechnology - Product Thumbnail Image

Industry Snapshots: US Biotechnology

  • Newsletter
  • November 2025
  • 50 Pages
  • United States
From
Large Molecule Injectable Drugs Market 2024-2028 - Product Thumbnail Image

Large Molecule Injectable Drugs Market 2024-2028

  • Report
  • July 2024
  • 166 Pages
  • Global
From
Hypophosphatasia Treatment Market Report 2025 - Product Thumbnail Image

Hypophosphatasia Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Anal Fissure Treatment Market Report 2025 - Product Thumbnail Image

Anal Fissure Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
Loading Indicator